The Pharma Data

NOVEMBER 4, 2020

(TSX: CTX) (OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house research & development (“R&D”) and manufacturing capabilities, today announced that it has entered into an exclusive agreement with Juyou-Biotechnology Co.

Licensing 40

Licensing Licensing Dermatology Production 40

XTalks

MAY 22, 2023

. “This unique product is a result of our vast experience in hyaluronic acid science and complements our current collection of hyaluronic acid products, with the Juvéderm collection of fillers and SkinMedica topicals.”

Filler 92

Filler FDA Approval Dermatology Production 92

Roots Analysis

JANUARY 29, 2024

Dermal Fillers: Aesthetic fillers are a great way to give your face a smoother, fuller look without having to go under anesthesia. General anesthesia is necessary for the procedure, and injections and fillers may also be used. These include increased public awareness and the presence of more licensed medical professionals.

Filler 40

Filler Cosmetics Botox Marketing 40

The Pharma Data

MAY 15, 2021

He brings a unique approach of mixing scientific research and in-the-trenches practical experience to bring a coach I truly admire. There was a big emphasis on mobility and flexibility, with many different fillers throughout each day. Marty Skele. Queensland, Australia. Eric, you are the best! The program was tough but enjoyable.

Production 52

Production Vaccination Vaccine Filler 52